172 related articles for article (PubMed ID: 36858520)
1. Recurrent Guillain-Barré Syndrome Associated with the Second Episode of Campylobacter jejuni Infection.
Takemoto K; Kawahara M; Atagi K
Intern Med; 2023 Oct; 62(20):3037-3041. PubMed ID: 36858520
[TBL] [Abstract][Full Text] [Related]
2. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
[TBL] [Abstract][Full Text] [Related]
3. Guillain Barré Syndrome is induced in Non-Obese Diabetic (NOD) mice following Campylobacter jejuni infection and is exacerbated by antibiotics.
St Charles JL; Bell JA; Gadsden BJ; Malik A; Cooke H; Van de Grift LK; Kim HY; Smith EJ; Mansfield LS
J Autoimmun; 2017 Feb; 77():11-38. PubMed ID: 27939129
[TBL] [Abstract][Full Text] [Related]
4. Ambiguous value of anti-ganglioside IgM autoantibodies in Guillain-Barré syndrome and its variants.
Koga M; Takahashi M; Yokoyama K; Kanda T
J Neurol; 2015 Aug; 262(8):1954-60. PubMed ID: 26050638
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to Zika virus,
Baskar D; Amalnath D; Mandal J; Dhodapkar R; Vanathi K
Neurol India; 2018; 66(5):1324-1331. PubMed ID: 30232998
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis.
Yuki N
Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987
[TBL] [Abstract][Full Text] [Related]
7. Low-Dose Exposure to Ganglioside-Mimicking Bacteria Tolerizes Human Macrophages to Guillain-Barré Syndrome-Associated Antigens.
Patry RT; Essler L; Andresen S; Quinn FD; Szymanski CM
mBio; 2021 Feb; 13(1):e0385221. PubMed ID: 35100875
[TBL] [Abstract][Full Text] [Related]
8. Subclass distribution and the secretory component of serum IgA anti-ganglioside antibodies in Guillain-Barré syndrome after Campylobacter jejuni enteritis.
Koga M; Yuki N; Hirata K
J Neuroimmunol; 1999 May; 96(2):245-50. PubMed ID: 10337924
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections.
Hao Q; Saida T; Kuroki S; Nishimura M; Nukina M; Obayashi H; Saida K
J Neuroimmunol; 1998 Jan; 81(1-2):116-26. PubMed ID: 9521613
[TBL] [Abstract][Full Text] [Related]
10. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes.
Koga M; Yuki N; Takahashi M; Saito K; Hirata K
J Neuroimmunol; 1998 Jan; 81(1-2):138-43. PubMed ID: 9521615
[TBL] [Abstract][Full Text] [Related]
11. Guillain-Barré syndrome-related Campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies.
Islam Z; Gilbert M; Mohammad QD; Klaij K; Li J; van Rijs W; Tio-Gillen AP; Talukder KA; Willison HJ; van Belkum A; Endtz HP; Jacobs BC
PLoS One; 2012; 7(8):e43976. PubMed ID: 22952833
[TBL] [Abstract][Full Text] [Related]
12. Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barre syndrome?
Kuwabara S; Ogawara K; Misawa S; Koga M; Mori M; Hiraga A; Kanesaka T; Hattori T; Yuki N
Neurology; 2004 Aug; 63(3):529-33. PubMed ID: 15304587
[TBL] [Abstract][Full Text] [Related]
13. Demyelinating Guillain-Barré syndrome recurs more frequently than axonal subtypes.
Notturno F; Kokubun N; Sekiguki Y; Nagashima T; De Lauretis A; Yuki N; Kuwabara S; Uncini A
J Neurol Sci; 2016 Jun; 365():132-6. PubMed ID: 27206890
[TBL] [Abstract][Full Text] [Related]
14. Co-infection with two different Campylobacter jejuni strains in a patient with the Guillain-Barré syndrome.
Godschalk PC; Gilbert M; Jacobs BC; Kramers T; Tio-Gillen AP; Ang CW; Van den Braak N; Li J; Verbrugh HA; Van Belkum A; Endtz HP
Microbes Infect; 2006 Jan; 8(1):248-53. PubMed ID: 16213180
[TBL] [Abstract][Full Text] [Related]
15. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
[TBL] [Abstract][Full Text] [Related]
16. [Anti-GQ1b IgG-negative case of overlapping Fisher's and Gullain-Barré syndromes after Campylobacter jejuni (PEN 19) enteritis].
Hayashi Y; Koga M; Takahashi M; Uchida A; Yuki N
Rinsho Shinkeigaku; 2001 Nov; 41(11):801-4. PubMed ID: 12080613
[TBL] [Abstract][Full Text] [Related]
17. Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh.
Islam Z; Jacobs BC; van Belkum A; Mohammad QD; Islam MB; Herbrink P; Diorditsa S; Luby SP; Talukder KA; Endtz HP
Neurology; 2010 Feb; 74(7):581-7. PubMed ID: 20157160
[TBL] [Abstract][Full Text] [Related]
18. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N
J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306
[TBL] [Abstract][Full Text] [Related]
19. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
Yuki N
J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
[TBL] [Abstract][Full Text] [Related]
20. A case of Guillain-Barré syndrome following a family outbreak of Campylobacter jejuni enteritis.
Ang CW; van Doorn PA; Endtz HP; Merkies IS; Jacobs BC; de Klerk MA; van Koningsveld R; van der Meché FG
J Neuroimmunol; 2000 Nov; 111(1-2):229-33. PubMed ID: 11063843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]